未登录

L

Liisa Hantsoo

department of psychiatry and behavioral sciences

H指数:30

被引数:3,958

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The PMADS project: a longitudinal multimodal cohort study to understand risk for perinatal mood and anxiety disorders

PMADS项目：一项纵向多模式队列研究，用于理解围产期心境和焦虑障碍的风险

IF3.6

2026-08-290

OA

Noemí Rubau-Apa; Caroline Hayes; Ashley Francisco; Sage Rush; Hudah Rana; Mahima Islam; Lily Hunter; Laura Pritschet; Taylor Salo; Suneeta Senapati; Liisa Hantsoo; Deepak Indrakanti; Emily M. Beydler; Erica B. Baller; Ran Barzilay; Monica E. Calkins; Matthew Cieslak; John A. Detre; Sammy Dhaliwal; Mark A. Elliott; Hao Huang; Arielle S. Keller; C. Brock Kirwan; Rachel Kishton; Tyler M. Moore; Sara L. Kornfield; J. Cobb Scott; Russell T. Shinohara; Manuel Taso; M. Dylan Tisdall; Arastoo Vossough; Lauren K. White; Kelly Zafman; Daniel H. Wolf; David R. Roalf; Sheila Shanmugan

The impact of adverse childhood experiences on gut microbiota and markers of inflammation is mediated by obesity and depression

不良儿童期经历对肠道菌群和炎症标志物的影响是由肥胖和抑郁介导的

brain, behavior, and immunity

IF0

2026-02-040

PRE

Barriers to Diagnosis and Treatment for Premenstrual Dysphoric Disorder (PMDD): A Scoping Review

前驱月经期心境恶劣障碍（PMDD）的诊断和治疗障碍：一项范围综述

REPRODUCTIVE SCIENCES

IF2.5

2025-04-180

PRE

Editorial: Psychiatric illness across the menstrual cycle

社论：月经周期中的精神障碍

FRONTIERS IN PSYCHIATRY

IF3.2

2025-02-120

OAAI

EPIGENETIC BIOMARKERS OF POSTPARTUM DEPRESSION IDENTIFY PREMENSTRUAL DYSPHORIC DISORDER (PMDD) AND POST-MENOPAUSAL DEPRESSION (PMD)

产后抑郁症的表观遗传生物标志物识别经前烦躁障碍（PMDD）和绝经后抑郁症（PMD）

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

IF3.7

2025-02-120

OA

Luteal phase sertraline treatment of premenstrual dysphoric disorder (PMDD): Effects on markers of hypothalamic pituitary adrenal (HPA) axis activation and inflammation

黄体期舍曲林治疗经前焦虑障碍 (PMDD): 对下丘脑垂体肾上腺 (HPA) 轴激活和炎症标志物的影响

PSYCHONEUROENDOCRINOLOGY

IF3.6

2024-11-012

PRE

The link between childhood traumatic events and the continuum of premenstrual disorders

FRONTIERS IN PSYCHIATRY

IF3.2

2024-10-091

OAAI

Premenstrual Dysphoric Disorder Affects Five Times as Many Individuals as Postpartum Depression, But Receives 80% Less NIH Research Funding

JOURNAL OF WOMENS HEALTH

IF1.9

2024-10-011

PRE

GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder

Gaba能神经活性类固醇对舍曲林在经前焦虑障碍中的反应

PSYCHONEUROENDOCRINOLOGY

IF3.6

2024-02-015

PRE

The role of the hypothalamic-pituitary-adrenal axis in depression across the female reproductive lifecycle: current knowledge and future directions

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-12-1222

OAAI

Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

IF7.9

2023-06-0116

OAAI

Maternal adverse childhood experiences impact fetal adrenal volume in a sex-specific manner

母亲的不良童年经历以性别特异性方式影响胎儿肾上腺容积

BIOLOGY OF SEX DIFFERENCES

IF5.1

2023-02-175

OAAI

Premenstrual symptoms across the lifespan in an international sample: data from a mobile application

国际样本中整个生命周期的经前症状: 来自移动应用程序的数据

ARCHIVES OF WOMENS MENTAL HEALTH

IF2.7

2022-08-2632

OAAI

Engagement in and Benefits of a Short-Term, Brief Psychotherapy Intervention for PTSD During Pregnancy

怀孕期间PTSD的短期短期心理治疗干预的参与和益处

FRONTIERS IN PSYCHIATRY

IF3.2

2022-06-150

OAAI

Patient Experiences of Health Care Providers in Premenstrual Dysphoric Disorder: Examining the Role of Provider Specialty

JOURNAL OF WOMENS HEALTH

IF1.9

2022-01-0113

OA

Symptom profiles of women at risk of mood disorders: A latent class analysis

有情绪障碍风险的女性的症状特征: 潜在类别分析

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2021-12-0113

PREAI

High worry in pregnancy predicts postpartum depression

怀孕期间的高度担忧预示着产后抑郁症

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2021-11-0122

OAAI

Allopregnanolone and depression and anxiety symptoms across the peripartum: an exploratory study

ARCHIVES OF WOMENS MENTAL HEALTH

IF2.7

2021-10-2913

OA

Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder

PSYCHOPHARMACOLOGY

IF3.3

2021-07-227

OAAI

Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone

CURRENT PSYCHIATRY REPORTS

IF6.7

2021-04-217

OAAI